UPC - Universe Pharmaceuticals INC

3.3
0.160   4.836%

Share volume: 6,651
Last Updated: 04-22-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.18%

PREVIOUS CLOSE
CHG
CHG%
$3.14
0.16
0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
-0.60%
1 Month
42.24%
3 Months
24.53%
6 Months
24.53%
1 Year
24.53%
2 Year
24.53%
Key data
Stock price
$3.30
P/E Ratio 
N/A
DAY RANGE
$3.12 - $3.40
EPS 
N/A
52 WEEK RANGE
$2.08 - $3.40
52 WEEK CHANGE
$24.53
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$6,569
AVERAGE 30 VOLUME 
$5,642
Company detail
CEO: Gang Lai
Region: US
Website: www.dzrzy.com/
Employees: 220
IPO year: 2026
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Universe Pharmaceuticals INC engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, and dietary supplements.

Recent news